Understanding how the tumor environment affects the delivery of nanoparticles for cancer treatment
The Tumor Microenvironment in Nanoparticle Delivery and Function
This study is looking at how the environment around tumors affects the way tiny particles that carry special RNA can help treat cancer, especially tough cases like triple negative breast cancer, with the hope of finding better, more personalized treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10845685 on NIH RePORTER |
What this research studies
This research investigates how the tumor microenvironment influences the effectiveness of nanoparticles that deliver small interfering RNA (siRNA) for cancer therapy. By using advanced imaging techniques like PET and MRI, the study aims to visualize and understand the delivery and function of these nanoparticles in tumors, particularly in challenging cancers like triple negative breast cancer. The approach combines molecular imaging with the development of biocompatible nanoparticles to enhance precision medicine in cancer treatment. Patients may benefit from insights that could lead to more effective therapies tailored to their specific tumor environments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with triple negative breast cancer or other cancers that lack targeted treatments.
Not a fit: Patients with cancers that are not responsive to siRNA therapies or those who do not have tumors suitable for nanoparticle delivery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved delivery methods for cancer treatments, enhancing their effectiveness and reducing side effects.
How similar studies have performed: Other research has shown promise in using nanoparticles for drug delivery in cancer treatment, indicating that this approach has potential for success.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Bhujwalla, Zaver M. — Johns Hopkins University
- Study coordinator: Bhujwalla, Zaver M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.